Yarrow Bioscience, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
YARW Nasdaq 2830 www.yarrowbioscience.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Yarrow Bioscience, Inc.

Yarrow Bioscience Reports Second Quarter 2026 Financial Results and Provides Business Update - Aug 13th, 2026 5:00 am
Yarrow Bioscience Announces Closing of Merger with VYNE Therapeutics and Initiation of Dosing in Phase 2a/2b Trial of YB-101, a Potential First-in-Class Treatment for Graves’ Disease and Thyroid Eye Disease - Jul 27th, 2026 5:00 am